ClearView Wealth Ltd (ASX: CVW) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

ClearView Wealth Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $345.50 million
P/E Ratio 21.12
Dividend Yield 0.00%
Shares Outstanding 628.17 million
Earnings per share 0.024
Dividend per share 0.06
Year To Date Return -1.82%
Earnings Yield 4.73%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • ClearView Wealth Ltd (ASX: CVW)
    Latest News

    Young investor sits at desk looking happy after discovering Westpac's dividend reinvestment plan
    Dividend Investing

    Buy these ASX dividend shares for big yields and 20% to 50% returns

    Brokers see major upside potential for these buy-rated shares.

    Read more »

    A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
    Dividend Investing

    Analysts say these cheap ASX dividend shares are buys

    These stocks could be cheap and have major upside potential and big yields.

    Read more »

    red percentage sign with man looking up which represents high interest rates
    Dividend Investing

    Buy these ASX dividend shares when interest rates fall

    Analysts expects great dividend yields from these buy-rated stocks.

    Read more »

    Man holding fifty Australian Dollar banknote in his hands, symbolising dividends, symbolising dividends.
    Dividend Investing

    These buy-rated ASX dividend shares offer 6.5%+ yields

    Brokers are expecting big yields from these stocks in the near term.

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Dividend Investing

    Top brokers say these high-yield ASX dividend shares are buys

    Big dividend yields are expected from these buy-rated stocks.

    Read more »

    Happy man holding Australian dollar notes, representing dividends.
    Dividend Investing

    2 excellent ASX dividend stocks that analysts love

    Analysts are tipping these stocks as a buys for income investors.

    Read more »

    A businessman hugs his computer and smiles.
    Dividend Investing

    Why analysts love these ASX dividend shares

    Brokers have good things to say about these income options.

    Read more »

    A couple lying down and laughing, symbolising passive income.
    Dividend Investing

    Are these the best ASX income stocks to buy now?

    Analysts have very good things to say about the income options.

    Read more »

    Beautiful young couple enjoying in shopping, symbolising passive income.
    Dividend Investing

    2 of the best ASX dividend stocks to buy in August

    Brokers think these shares are top buys this month. But why?

    Read more »

    A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
    Broker Notes

    Morgans names the best ASX stocks to buy in July

    What is the broker saying about these stocks this month?

    Read more »

    A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
    Broker Notes

    Morgans names more of the best ASX stocks to buy in June

    These ASX stocks are highly rated by analysts at Morgans in June.

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why Clearview, Loyal Lithium, Polynovo, and Weebit Nano shares are falling

    These shares are ending the week deep in the red. But why?

    Read more »

    Frequently Asked Questions

    Yes, ClearView Wealth has historically paid one fully franked shareholder dividend a year

    ClearView generally pays its shareholder dividend each September. 

    ClearView Wealth Ltd listed on the ASX on 11 December 2003.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2024 $0.0170 100.00% Final 20 Sep 2024
    07 Mar 2024 $0.0150 100.00% Interim 23 Mar 2024
    06 Sep 2023 $0.0300 100.00% Final 22 Sep 2023
    07 Sep 2022 $0.0200 100.00% Final 23 Sep 2022
    08 Sep 2021 $0.0100 100.00% Final 24 Sep 2021
    11 Sep 2018 $0.0300 100.00% Final 28 Sep 2018
    12 Sep 2017 $0.0000 100.00% Final 29 Sep 2017
    15 Sep 2016 $0.0250 100.00% Final 30 Sep 2016
    02 Sep 2014 $0.0200 100.00% Final 17 Sep 2014
    24 Sep 2013 $0.0180 100.00% Final 08 Oct 2013
    05 Mar 2008 $0.0400 100.00% Interim 28 Mar 2008
    17 Sep 2007 $0.0400 100.00% Final 05 Oct 2007
    05 Mar 2007 $0.0400 0.00% Interim 23 Mar 2007
    01 Sep 2006 $0.0300 100.00% Final 21 Sep 2006
    06 Mar 2006 $0.0300 100.00% Interim 23 Mar 2006
    02 Sep 2005 $0.0200 100.00% Final 22 Sep 2005

    CVW ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About ClearView Wealth Ltd

    ClearView Wealth Ltd (ASX: CVW) is a diversified financial services company offering life insurance, superannuation, and wealth management products and services. The company partners with financial and insurance advisors, with about 4,000 advisors currently selling ClearView products and services.

    CVW Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    19 Feb 2026 $0.55 $0.01 1.85% 113,737 $0.54 $0.55 $0.53
    18 Feb 2026 $0.54 $0.01 1.87% 45,471 $0.54 $0.54 $0.53
    17 Feb 2026 $0.54 $-0.01 -1.85% 178,795 $0.54 $0.54 $0.53
    16 Feb 2026 $0.54 $0.03 5.83% 176,592 $0.52 $0.54 $0.52
    13 Feb 2026 $0.52 $0.00 0.00% 32,373 $0.52 $0.53 $0.52
    12 Feb 2026 $0.52 $-0.02 -3.77% 311,079 $0.54 $0.55 $0.52
    11 Feb 2026 $0.53 $-0.03 -5.36% 24,084 $0.54 $0.55 $0.53
    10 Feb 2026 $0.56 $0.01 1.80% 269,134 $0.56 $0.56 $0.56
    09 Feb 2026 $0.56 $0.05 9.80% 502,382 $0.52 $0.56 $0.52
    06 Feb 2026 $0.51 $-0.01 -1.92% 283,903 $0.52 $0.52 $0.50
    05 Feb 2026 $0.52 $-0.03 -5.45% 56,351 $0.53 $0.54 $0.52
    04 Feb 2026 $0.55 $0.01 1.85% 369,651 $0.58 $0.58 $0.53
    03 Feb 2026 $0.54 $0.02 3.85% 68,664 $0.53 $0.54 $0.52
    02 Feb 2026 $0.52 $0.00 0.00% 23,335 $0.55 $0.55 $0.51
    30 Jan 2026 $0.52 $-0.01 -1.90% 76,729 $0.55 $0.55 $0.52
    29 Jan 2026 $0.53 $0.01 1.92% 156,811 $0.52 $0.54 $0.52
    28 Jan 2026 $0.52 $-0.01 -1.89% 374,710 $0.53 $0.53 $0.52
    27 Jan 2026 $0.53 $-0.01 -1.87% 167,686 $0.54 $0.55 $0.53
    23 Jan 2026 $0.54 $-0.01 -1.83% 54,239 $0.55 $0.55 $0.54
    22 Jan 2026 $0.55 $0.01 1.85% 202,481 $0.54 $0.55 $0.54
    21 Jan 2026 $0.54 $0.01 1.87% 103,427 $0.53 $0.54 $0.53

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    13 Nov 2025 Nadine Gooderick Issued 1,780,621 $1,032,760
    Issue of securities. 44,94,336 Rights
    13 Nov 2025 Nadine Gooderick Expiry 277,777 $161,110
    As advised by the company. 2713715 Rights, Lapsed
    13 Nov 2025 Nadine Gooderick Issued 63,756 $36,978
    Issue of securities.
    06 Nov 2025 Nadine Gooderick Issued 63,756 $37,616
    Conversion of securities.
    06 Nov 2025 Nadine Gooderick Expiry 277,777 $163,888
    As advised by the company. Lapsed, 2713715 Rights
    06 Nov 2025 Nadine Gooderick Issued 1,780,621 $1,050,566
    Issue of securities. 4494336 Rights
    06 Nov 2025 Nadine Gooderick Exercise 63,756 $37,616
    Conversion of securities. 4,430,580 Rights
    16 Apr 2025 Edward Fabrizio Buy 25,000 $11,125
    On-market trade.
    12 Mar 2025 Jennifer Lyon Buy 41,666 $19,993
    On-market trade.
    06 Mar 2025 Geoffrey Black Buy 100,000 $44,000
    On-market trade.
    06 Mar 2025 Nadine Gooderick Buy 395,821 $180,251
    On-market trade. As per announcement on 10-03-2025

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Gary Zalman Burg Non-Executive Director Oct 2012
    Mr Burg has experience in building life insurance businesses in South Africa and in Australia. He currently serves as a member of the Board Risk and Compliance Committee and the Board Investment Committee.
    Mr Michael Thomas Alscher Non-Executive Director Apr 2024
    Mr Alscher is the Managing Partner and founder of Crescent Capital Partners Management Pty Limited. Prior to founding Crescent Capital Partners, he was a consultant at Bain International and the LEK Partnership where he spent considerable time working across banking and insurance clients. He is the current Chairman of Green Leaves Early Learning Centres Pty Ltd and Bremick Pty Ltd. He is also a non executive director of New Zealand Panels Group Limited and Steel Mains Holdings Pty Ltd. He was re appointed to the Board on 24 May 2024, following a period as Alternate Director for Eloise Watson. In addition to his Board appointment, he also serves as a member of the Board Investment Committee.
    Ms Linda Scott Non-Executive Director Jun 2025
    Ms Scott is the Chair of CareSuper and the Chair of the charity, Alcohol and Drug Foundation (ADF). She is a Director of the Australian Council of Superannuation Investors (ACSI), a Director of Industry Innovation and Science Australia (IISA), and a member of the Director Nomination Committee of IFM Investors. She is also Chair and Commissioner of the NSW Local Government Grants Commission, and a Director of the Powerhouse, the largest museum group in Australia. She previously served as the elected President of the Australian Local Government Association (ALGA), attending National Cabinet and a wide variety of Ministerial councils. She was the first woman elected as President of Local Government NSW and served as the City of Sydneys Deputy Lord Mayor and as a Councillor for more than a decade. She has also served on a range of other boards and taskforces, including the Commonwealth Governments Regional Banking Taskforce, CSIROs External Advisory Group on Ending Plastic Waste and the NSW Environmental Trust. She currently serves as a member of the Board Risk and Compliance Committee.
    Mr Nathanial Jonothan Thomson Non-Executive Director Oct 2012
    Mr Thomson is a partner of Crescent Capital Partners Management Pty Limited, a leading Australian private equity investment firm. He has over 20 years of experience from his prior role at McKinsey & Co. He is the current Chair and non executive director of Cardno Limited, National Dental Care Limited, Clover Insurance and AireSafe International Pty Ltd. He is also a non executive director of Emapta and Greenleaves. He currently serves as an alternate member for Michael Alscher on the Board Investment Committee.
    Mr Geoffrey Murray Black Non-Executive DirectorNon-Executive Chairman Nov 2019
    Mr Black has over 30 years of experience in life insurance and wealth management and is currently a director of Platypus Asset Management and was Head of Business Development at RGA Australia. Prior to joining the ClearView Board he held senior executive positions at RGA Australia, TAL Australia and was formerly Managing Director of PrefSure Life and Lumley Life Limited. He was appointed to the Board on 25 November 2019 and appointed as Chair of the Board on 1 July 2020. He is a member of the Risk and Compliance Committee.
    Ms Jennifer Lyon Non-Executive Director Jul 2020
    Ms Lyon is an experienced actuary, small business owner and Director. She was a founding owner of recruitment firm SKL Executive and served as a Director until December 2020. She has also formerly held a number of senior and Director positions including non-executive Director and President of the Actuaries Institute of Australia, Managing Director of QED Actuarial, a specialist actuarial recruitment firm, a Director of Hall & Lyon which managed the distribution of actuarial education material, and worked at AMP and Towers Perrin in superannuation and financial services. She is a member and Chair of both the Board Risk and Compliance Committee.
    Mr Edward Fabrizio Non-Executive Director Jun 2023
    Mr Fabrizio is an experienced life insurance actuary with over 30 years of experience and has been operating his own actuarial consulting business since 2016. Prior to joining the ClearView Board he was the Managing Director of General Reinsurance Life Australia, a Non Executive Director and Council Member of the Institute of Actuaries of Australia, Director in KPMGs Actuarial practice as well as the Appointed Actuary for various life insurance and reinsurance companies. He is Chair of the Board Investment Committee and a member of the Board Risk and Compliance Committee.
    Ms Nadine Gooderick Chief Executive OfficerManaging Director Jul 2023
    Ms Gooderick is a life insurance leader with experience managing international programs and leading large diverse teams across different functions and markets. She spent almost 25 years at RGA Reinsurance, including the last eight years as Chief Operating Officer for Australia and New Zealand from 2011 to 2019. In that role, she had responsibility for the key functions of underwriting, medical and technical services, claims and operations as well as project management. Prior to that, she was Vice President, Asia Pacific Regional Office. At RGA, her career highlights include the startup of several of RGAs International Offices as part of the groups global expansion into Asia and Europe as well as the delivery of a substantial, multiyear transformation program for the management of disability income and TPD insurance claims; and the delivery of an end to end group administration system over two years.
    Ms Judilyn Beaumont Company SecretaryGeneral Counsel Nov 2019
    -
    Ashutosh Bhalerao Appointed Actuary
    -
    Athol Chiert Chief Financial Officer
    -
    Michael New Chief Technology Officer
    -
    Judilyn Beaumont Company SecretaryGeneral Counsel
    -
    Christopher Blaxland Walker Group Executive Distribution
    -
    Joanne Faglioni Group Executive Operations
    -
    Nick Kulikov Group Executive Product and Pricing
    -
    Judilyn Beaumont Group Executive General Counsel Corporate Chief Risk Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Citicorp Nominees Pty Limited 172,819,572 26.74%
    Perpetual Corporate Trust Limited <Roc Cvw Co Investment A/C> 64,215,477 9.94%
    Ccp Trusco 4 Pty Limited <Ccp Designated Tst Iva A/C> 41,802,002 6.47%
    Ccp Bidco Pty Limited <Ccp Bidco Tst 2 A/C> 32,406,173 5.01%
    Ccp Trusco 5 Pty Limited <Ccp Designated Tst Ivb A/C> 29,631,331 4.58%
    Ccp Trusco 1 Pty Limited <Ccp Specific Tst Iva A/C> 27,296,087 4.22%
    J P Morgan Nominees Australia Pty Limited 22,923,187 3.55%
    Ccp Trusco 3 Pty Limited <Ccp Specific Tst Ivc A/C> 15,597,762 2.41%
    Ccp Trusco 2 Pty Limited <Ccp Specific Tst Ivb A/C> 12,998,136 2.01%
    Wintol Pty Ltd 10,827,624 1.68%
    Portfolio Services Pty Ltd 10,304,057 1.59%
    HSBC Custody Nominees (Australia) Limited 9,226,704 1.43%
    HSBC Custody Nominees (Australia) Limited A/C 2 8,555,502 1.32%
    Perpetual Trustee Company Ltd <Roc Pif> 7,716,101 1.19%
    UBS Nominees Pty Ltd 6,895,624 1.07%
    Tamim Investments Pty Limited <Tamim Tvg Spv1 A/C> 6,502,030 1.01%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 6,310,740 0.98%
    Wintol Pty Ltd <The Gz Burg Family A/C> 6,302,827 0.98%
    Manyata Holdings Pty Limited <Swanson Family A/C> 5,550,000 0.86%
    Abn Amro Clearing Sydney Nominees Pty Ltd <Custodian A/C> 5,201,786 0.80%

    Profile

    since

    Note